Nasdaq - Delayed Quote USD

T. Rowe Price Health Sciences I (THISX)

75.01
+1.34
+(1.82%)
At close: 8:02:16 PM EDT

Top 9 Holdings (44.34% of Total Assets)

SymbolCompany% Assets
Eli Lilly and Company 10.71%
UnitedHealth Group Incorporated 7.31%
Intuitive Surgical, Inc. 4.92%
Stryker Corporation 4.45%
Thermo Fisher Scientific Inc. 3.94%
argenx SE 3.54%
Vertex Pharmaceuticals Incorporated 3.27%
Boston Scientific Corporation 3.13%
Danaher Corporation 3.07%

Sector Weightings

SectorTHISX
Healthcare   99.91%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 0.79%
Stocks 90.23%
Bonds 0.00%
Others 8.83%
Preferred 0.00%
Convertible 0.15%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average THISX Category Average
Price/Earnings 0.03 24.55
Price/Book 0.2 5.28
Price/Sales 0.46 2.06
Price/Cashflow 0.05 17.54
Median Market Cap 77,030.15 34,862.81
3 Year Earnings Growth 5.85 32.48

Bond Holdings

Average THISX Category Average
Maturity -- --
Duration 2.5 --
Credit Quality -- --

Performance & Risk

YTD Return -7.58%
5y Average Return 4.08%
Rank in Category (ytd) 37
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.69
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family T. Rowe Price
Net Assets 12.07B
YTD Return -0.06%
Yield 0.18%
Morningstar Rating
Inception Date Mar 23, 2016

Fund Summary

The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

Related Tickers